NBIX - Neurocrine Biosciences Inc.

$180.51 as of 2026-07-09 · Healthcare · Drug Manufacturers - Specialty & Generic · Stock

NBIX (Neurocrine Biosciences Inc.) is the #493 most-held security of 2,507 tracked on Upside Invest, held by 4 retail investors (1% of tracked portfolios), at an average allocation of 0.4% of their portfolio.

• Popularity rank: #493 of 2,507
• Holders on Upside: 4 retail investors
• Average allocation: 0.4%
• Average holder gain/loss: +158.0%
• Stock grade: B
• 30-day trading activity: 0 buys / 0 sells
• Market cap: $18.0B

Related Healthcare securities: LLY, UNH, HIMS, NVO, PFE

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.